Home > Pressrelease > Synthetic Biology Market size to exceed $55bn by 2025

Synthetic Biology Market size to exceed $55bn by 2025

  • Published Date: June 11, 2019

Synthetic Biology Market size is estimated to exceed USD 55 billion by 2025, according to a new research report by Global Market Insights Inc.

Increasing investment by the private sector to accentuate new possibilities emerging from synthetic biology techniques such as cloning, sequencing, gene synthesis, genome engineering, and nanotechnology will support the overall market growth. Potential positive impacts of components, organisms, and products resulting from synthetic biology techniques will promulgate the market growth for the forecast timeframe. Additionally, Rising prevalence of chronic diseases among the adults and the geriatric population will further boost the development of genetically modified products and organ-on-chip technologies for pharmaceuticals and diagnostics applications.

Synthetic Biology Market

Get more details on this report - Request Free Sample PDF

Favorable governments policies and guidelines for the promotion of the technology coupled with rising investment by private organizations and research institutes will fuel overall industry demand.

Key factors including rising concerns regarding fuel consumption and increasing demand for novel synthetic biology technologies including protein therapeutics and gene synthesis products in research institutes and academic will provide lucrative opportunities for the industry participants. Growing awareness regarding the use of green and environmentally friendly materials such as biofuels owing to declining fossil fuel will further stimulate the demand for the product. However, uncertainty in government policies, environmental and security-related issues concerning to genetic modification may hamper the synthetic biology industry growth.

Browse key industry insights spread across 250 pages with 170 market data tables & 15 charts & figures from the report, “Synthetic Biology Market Size By Product (Core Products, Enabling Products, Enabled Products), By Technology (Nucleotide Synthesis And Sequencing, Bioinformatics, Microfluidics, Genetic Engineering), By Application (Pharmaceuticals And Diagnostics, Chemicals, R&D, Agriculture, Energy), Industry Analysis Report, Regional, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025” in detail along with the table of contents:

Core products segment is set to register more than 25% CAGR between 2019 and 2025. Advancements in the technology such as microchip-based gene synthesis and sequencing will augment the product demand in numerous end-use applications. Moreover, factors such as higher investments required in producing genetically modified plants and favorable government policies towards the use of natural biological systems will augment the product demand.

Nucleotide synthesis and sequencing accounted for more than 45% of the synthetic biology market share in 2018. Growing application of the technology in molecular diagnosis of inherited disorders have enhanced the scope of the product. Moreover, development of new sets of protecting amino groups, better coupling reagents, and high-throughput synthesizers has revolutionized the nucleotide synthesis and sequencing process for therapeutic and diagnostic applications.

Pharmaceuticals and diagnostic application accounted for more than 75% of market share in 2018. Factors such as integration of custom engineering methods coupled with technological advancement in genetic engineering methods have enabled the development of pharmaceutical drugs with reliable results and high accuracy.  Synthetic biology offers a potential platform for the discovery of future medicines, where genetically engineered cells can fight diseases such as cancer and diabetes. Rising prevalence of diabetes and obesity among adults and young populace will propel the product demand.

Europe synthetic biology market is set to register over 25% CAGR from 2019 to 2025. Presence of major academic institutions, private companies and strength in biotechnology research, are among the key reasons for high growth across the region. Huge investments and government funding will contribute significantly towards the regional growth. For instance, EraSynbio project funded by EU has led out a strategic plan to encourage the development of coordinated and coherent European policy framework. Increase in innovations carried out in the field of synthetic biology such as the development of toolkit of novel proteins, that can be used as synthetic building blocks for biomaterials has proliferated market growth in this region.

Amyris, GenScript, DNA2.0, Evolva, DSM, Integrated DNA technologies, Twist biosciences, Editas Medicine, Inc., Pareto Biotechnologies, Blue heron, TeselaGenSyntrox Inc, and Thermo Fischer Scientific are among the major companies involved in synthetic biology market. Due to the presence of dominating players in the market, industry share is highly competitive in nature. Collaborations, mergers & acquisitions, and product enhancements are among the key strategies adopted by major market players for enhancing their global market share. For instance, in July 2017, DSM announced to partner with Amyris Inc, a synthetic biology company for the development of food and nutrition molecule technology. This intuitive will help DSM in reducing the cost for products using technology platform of Amyris Inc.

Authors: Kunal Ahuja, Amit Rawat